Stereoselective Synthesis of C-Aryl-α-Glycosides by Reductive C(sp2)–C(sp3) Cross-Coupling Reaction

Noyuri Kudo; Suzuka Chiba; Shunsuke Ono; Masataka Nagatoishi; Makoto Yoritate; Satoru Karasawa; Kazuteru Usui; Go Hirai

doi:10.1055/a-2352-4760

Synlett, Inhaltsverzeichnis

Synlett 2025; 36(04): 357-362
DOI: 10.1055/a-2352-4760

letter

Stereoselective Synthesis of C-Aryl-α-Glycosides by Reductive C(sp²)–C(sp³) Cross-Coupling Reaction

Noyuri Kudo‡

^aGraduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

,

Suzuka Chiba‡

^aGraduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

,

Shunsuke Ono

^aGraduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

,

Masataka Nagatoishi

^aGraduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

,

Makoto Yoritate

^aGraduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

,

Satoru Karasawa

^bShowa Pharmaceutical University, Machida, Tokyo, 194-8543, Japan

,

Kazuteru Usui∗

^aGraduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

^bShowa Pharmaceutical University, Machida, Tokyo, 194-8543, Japan

,

Go Hirai ∗

^aGraduate School of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

C-Aryl glycosides have attracted considerable interest as biologically active natural products and as O-aryl glycoside mimetics in drug discovery. Here, we describe a straightforward synthesis of C-aryl glycosides by photoredox/Ni dual-catalyzed reductive cross-coupling between glycosyl bromides and aryl bromides. This methodology enables a highly α-stereoselective synthesis of C-aryl glucosides, galactosides, and mannosides.

Key words

glycosides - photoredox catalysis - nickel catalysis - cross-coupling - stereoselectivity - conformational restriction

Volltext

Referenzen

References and Notes

1a Suzuki K. Pure Appl. Chem. 1994; 66: 2175
1b Hansen MR, Hurley LH. Acc. Chem. Res. 1996; 29: 249
1c Lee DY. W, He M. Curr. Top. Med. Chem (Sharjah, United Arab Emirates) 2005; 5: 1333

2a Meng W, Ellsworth BA, Nirschl AA, McCann PJ, Patel M, Girotra RN, Wu G, Sher PM, Morrison EP, Biller SA, Zahler R, Deshpande PP, Pullockaran A, Hagan DL, Morgan N, Taylor JR, Obermeier MT, Humphreys WG, Khanna A, Discenza L, Robertson JG, Wang A, Han S, Wetterau JR, Janovitz EB, Flint OP, Whaley JM, Washburn WN. J. Med. Chem. 2008; 51: 1145
2b Xu B, Feng Y, Cheng H, Song Y, Lv B, Wu Y, Wang C, Li S, Xu M, Du J, Peng K, Dong J, Zhang W, Zhang T, Zhu L, Ding H, Sheng Z, Welihinda A, Roberge JY, Seed B, Chen Y. Bioorg. Med. Chem. Lett. 2011; 21: 4465

3a Chao EC, Henry RR. Nat. Rev. Drug Discovery 2010; 9: 551
3b Aguillón AR, Mascarello A, Segretti ND, de Azevedo HF. Z, Guimaraes CR. W, Miranda LS. M, de Souza RO. M. A. Org. Process Res. Dev. 2018; 22: 467

4a Tomiyama H, Yanagisawa T, Nimura M, Noda A, Tomiyama T. US 6635622, 2003
4b Yang G, Schmieg J, Tsuji M, Franck RW. Angew. Chem. Int. Ed. 2004; 43: 3818
4c Chen G, Schmieg J, Tsuji M, Franck RW. Org. Lett. 2004; 6: 4077
4d Toba T, Murata K, Yamamura T, Miyake S, Annoura H. Tetrahedron Lett. 2005; 46: 5043
4e Lu X, Song L, Metelitsa LS, Bittman R. ChemBioChem 2006; 7: 1750
4f Wipf P, Pierce JG. Org. Lett. 2006; 8: 3375
4g Liu Z, Byun H.-S, Bittman R. Org. Lett. 2010; 12: 2974
4h Altiti AS, Mootoo DR. Org. Lett. 2014; 16: 1466
4i Chang Y.-J, Hsuan Y.-C, Lai AC.-Y, Han Y.-C, Hou D.-R. Org. Lett. 2016; 18: 808
4j Altiti AS, Bachan S, Mootoo DR. Org. Lett. 2016; 18: 4654
4k Hidaka Y, Kiya N, Yoritate M, Usui K, Hirai G. Chem. Commun. 2020; 56: 4712

For recent representative reports on KRN7000, see:

5a Inuki S, Kashiwabara E, Hirata N, Kishi J, Nabika E, Fujimoto Y. Angew. Chem. Int. Ed. 2018; 57: 9655
5b Hossain MI, Hanashima S, Nomura T, Lethu S, Tsuchikawa H, Murata M, Kusaka H, Kita S, Maenaka K. Bioorg. Med. Chem. 2016; 24: 3687
5c Janssens J, Decruy T, Venken K, Seki T, Krols S, Van der Eycken J, Tsuji M, Elewaut D, Van Calenbergh S. ACS Med. Chem. Lett. 2017; 8: 642
5d Guillaume J, Wang J, Janssens J, Remesh SG, Risseeuw MD. P, Decruy T, Froeyen M, Elewaut D, Zajonc DM, Van Calenbergh S. Sci. Rep. 2017; 7: 4276
5e Chennamadhavuni D, Saavedra-Avila NA, Carreño LJ, Guberman-Pfeffer MJ, Arora P, Yongqing T, Pryce R, Koay H.-F, Godfrey DI, Keshipeddy S, Richardson SK, Sundararaj S, Lo JH, Wen X, Gascón JA, Yuan W, Rossjohn J, Le Nours J, Porcelli SA, Howell AR. Cell Chem. Biol. 2018; 25: 571
5f Hwang YS, Yim J, Song H, Park SB. ACS Med. Chem. Lett. 2019; 10: 720

For selected reviews on C-glycosides, see:

6a Du Y, Linhardt RJ, Vlahov IR. Tetrahedron 1998; 54: 9913
6b Bokor É, Kun S, Goyard D, Tóth M, Praly J.-P, Vidal S, Somsák L. Chem. Rev. 2017; 117: 1687
6c Yang Y, Yu B. Chem. Rev. 2017; 117: 12281
6d Kitamura K, Ando Y, Matsumoto T, Suzuki K. Chem. Rev. 2018; 118: 1495
6e Shang W, Niu D. Acc. Chem. Res. 2023; 56: 2473
6f Jiang Y, Zhang Y, Lee BC, Koh MJ. Angew. Chem. Int. Ed. 2023; 62: e202305138
6g Parida SP, Das T, Ahemad MA, Pati T, Mohapatra S, Nayak S. Carbohydr. Res. 2023; 530: 108856

7 Gong H, Gagné MR. J. Am. Chem. Soc. 2008; 130: 12177

8a Nicolas L, Angibaud P, Stansfield I, Bonnet P, Meerpoel L, Reymond S, Cossy J. Angew. Chem. Int. Ed. 2012; 51: 11101
8b Nicolas L, Izquierdo E, Angibaud P, Stansfield I, Meerpoel L, Reymond S, Cossy J. J. Org. Chem. 2013; 78: 11807

9 Adak L, Kawamura S, Toma G, Takenaka T, Isozaki K, Takaya H, Orita A, Li HC, Shing TK. M, Nakamura M. J. Am. Chem. Soc. 2017; 139: 10693

10a Zhu F, Rourke MJ, Yang T, Rodriguez J, Walczak MA. J. Am. Chem. Soc. 2016; 138: 12049
10b Zhu F, Rodriguez J, Yang T, Kevlishvili I, Miller E, Yi D, O’Neill S, Rourke MJ, Liu P, Walczak MA. J. Am. Chem. Soc. 2017; 139: 17908
10c Yi D, Zhu F, Walczak MA. Org. Lett. 2018; 20: 4627
10d Yi D, Zhu F, Walczak MA. Org. Lett. 2018; 20: 1936

11 Liu J, Gong H. Org. Lett. 2018; 20: 7991
12 The β-selective preparation of C-aryl glycosides is possible by employing tBu₃terpy as the ligand; see: Liu J, Lei C, Gong H. Sci. China Chem. 2019; 62: 1492
13 For a selected review on the synthesis of C-aryl glycosides by C–H functionalization, see: Gou X.-Y, Zhu X.-Y, Zhang B.-S, Liang Y.-M. Chem. Eur. J. 2023; 29: e202203351
14 Moriyama T, Yoritate M, Kato N, Saika A, Kusuhara W, Ono S, Nagatake T, Koshino H, Kiya N, Moritsuka N, Tanabe R, Hidaka Y, Usui K, Chiba S, Kudo N, Nakahashi R, Igawa K, Matoba H, Tomooka K, Ishikawa E, Takahashi S, Kunisawa J, Yamasaki S, Hirai G. J. Am. Chem. Soc. 2024; 146: 2237
15 Hirai G, Kato M, Koshino H, Nishizawa E, Oonuma K, Ota E, Watanabe T, Hashizume D, Tamura Y, Okada M, Miyagi T, Sodeoka M. JACS Au 2020; 1: 137
16 For a photoredox reaction with allyl glycosyl sulphone donors, see: Zhang C, Xu S.-Y, Zuo H, Zhang X, Dang Q.-D, Niu D. Nat. Synth. 2023; 2: 251

For photoredox reactions with glycosyl halide donors, see:

17a Mou Z.-D, Wang J.-X, Zhang X, Niu D. Adv. Synth. Catal. 2021; 363: 3025
17b Xia L, Fan W, Yuan X.-A, Yu S. ACS Catal. 2021; 11: 9397
17c Jiao Y, Shi X, Ju L, Yu S. Org. Lett. 2024; 26: 390
17d Jiao Y, Shi X, Ju L, Yu S. Org. Lett. 2024; 26: 390
17e Jiao Y, Shi X, Ju L, Yu S. Org. Lett. 2024; 26: 390
17f Jiao Y, Shi X, Yu S. Chem. Commun. 2023; 59: 13336

For photoredox reactions with glycosyl trifluoroborate donors, see:

18a Takeda D, Yoritate M, Yasutomi H, Chiba S, Moriyama T, Yokoo A, Usui K, Hirai G. Org. Lett. 2021; 23: 1940
18b Miller EM, Walczak MA. Org. Lett. 2021; 23: 4289

19 For a photoredox reaction with glycosyl ester donors, see: Wei Y, Ben-zvi B, Diao T. Angew. Chem. Int. Ed. 2021; 60: 9433

For selected examples of the synthesis of aliphatic C-glycosides, see:

20a Badir SO, Dumoulin A, Matsui JK, Molander GA. Angew. Chem. Int. Ed. 2018; 57: 6610
20b Xia L, Jin M, Jiao Y, Yu S. Org. Lett. 2021; 24: 364
20c Wei Y, Lam J, Diao T. Chem. Sci. 2021; 12: 11414
20d Miura T, Yoritate M, Hirai G. Chem. Commun. 2023; 59: 8564
20e Chen A, Zhao S, Han Y, Zhou Z, Yang B, Xie L.-G, Walczak MA, Zhu F. Chem. Sci. 2023; 14: 7569

21a Zhang P, Le C, MacMillan DW. C. J. Am. Chem. Soc. 2016; 138: 8084
21b Smith RT, Zhang X, Rincón JA, Agejas J, Mateos C, Barberis M, García-Cerrada S, de Frutos O, MacMillan DW. C. J. Am. Chem. Soc. 2018; 140: 17433

For other approaches by photoredox/Ni dual-catalyzed reductive cross-coupling of alkyl halides with aryl and vinyl halides, see:

22a Duan Z, Li W, Lei A. Org. Lett. 2016; 18: 4012
22b Paul A, Smith MD, Vannucci AK. J. Org. Chem. 2017; 82: 1996
22c Peng L, Li Z, Yin G. Org. Lett. 2018; 20: 1880
22d Yu W, Chen L, Tao J, Wang T, Fu J. Chem. Commun. 2019; 55: 5918
22e Lu Q, Guan H, Wang Y.-E, Xiong D, Lin T, Xue F, Mao J. J. Org. Chem. 2022; 87: 8048

23a Korth HG, Sustmann R, Groeninger KS, Leisung M, Giese B. J. Org. Chem. 1988; 53: 4364
23b Abe H, Terauchi M, Matsuda A, Shuto S. J. Org. Chem. 2003; 68: 7439
23c Manabe S, Aihara Y, Ito Y. Chem. Commun. 2011; 47: 9720
23d Satoh H, Manabe S. Chem. Soc. Rev. 2013; 42: 4297

24 For our recent studies on the controlled α-selective synthesis of CH₂-linked (1,6)-disaccharides and CH₂-linked glycosylceramides by direct radical coupling C-glycosylation of a C1–sp³ hybridized donor adopting a restricted ⁴C₁ conformation, see: Kiya N, Hidaka Y, Usui K, Hirai G. Org. Lett. 2019; 21: 1588 ; see also ref. 4k
25 The [Ir]/[Ni] molar ratio was determined based on the optimized conditions of Ref. 14.
26 The stereoselectivity of the coupling product was determined based on the corresponding deacetylated derivative (see SI).

27a Fu Y, Liu L, Yu H.-Z, Wang Y.-M, Guo Q.-X. J. Am. Chem. Soc. 2005; 127: 7227
27b Noble A, Mega RS, Pflästerer D, Myers EL, Aggarwal VK. Angew. Chem. Int. Ed. 2018; 57: 2155

28 In most cases, only α-anomers were produced, except in the case of glycoside o-3aa (α/β = 8:1). It should be noted that after column purification, the β-anomer was not detected.

29a Manabe S, Ito Y. J. Am. Chem. Soc. 1999; 121: 9754
29b Nishikawa T, Ishikawa M, Wada K, Isobe M. Synlett 2001; 945
29c Manabe S, Sakamoto K, Nakahara Y, Sisido M, Hohsaka T, Ito Y. Bioorg. Med. Chem. 2002; 10: 573
29d Nishikawa T, Koide Y, Kajii S, Wada K, Ishikawa M, Isobe M. Org. Biomol. Chem. 2005; 3: 687
29e Nishikawa T, Koide Y, Kanakubo A, Yoshimura H, Isobe M. Org. Biomol. Chem. 2006; 4: 1268
29f Mao R, Xi S, Shah S, Roy MJ, John A, Lingford JP, Gäde G, Scott NE, Goddard-Borger ED. J. Am. Chem. Soc. 2021; 143: 12699

30 C-Aryl-α-Glycosides 3aa–co; General Procedure A 10 mL vial was charged with NiCl₂·DME (11.0 mg, 50.1 μmol), dtbbpy (16.0 mg, 59.6 μmol), and MeCN (5.0 mL) in air, and the mixture was sonicated to give a blue solution of the ligated Ni complex (10 mM in MeCN stock solution). This solution (500 μL, 5.0 μmol, 10 mol%) was added to a 4 mL vial, concentrated by blowing N₂, and dried in vacuo. To the vial were sequentially added the appropriate glycosyl bromide 1 (75.0 μmol, 1.5 equiv), (het)aryl bromide 2 (50.0 μmol, 1.0 equiv), {Ir[dFCF₃ppy]₂(dtbbpy)PF₆} (2.8 mg, 2.5 μmol, 5 mol%), DME (500 μL), 2,4,6-collidine (13 μL, 100 μmol, 2.0 equiv), and TMSSiOH (23 μL, 75 μmol, 1.5 equiv). The vial was sealed and the mixture was stirred and irradiated by a blue LED for 12 h at 28–30 °C. The mixture was then exposed to air, filtered through Celite (rinsed with 1:1 hexane–EtOAc), then concentrated. The residue was purified by recycling GPC (CHCl₃) and short-column chromatography (silica gel). 3aa Prepared by the general procedure from 1a (26.5 mg, 75.0 μmol, 1.5 equiv) and p-2a (10.8 mg, 50.0 μmol, 1.0 equiv), and purified by GPC and short-column chromatography [silica gel, hexane–EtOAc (9:1 to 2:1)] to give a white solid; yield: 10.8 mg (53%), [α]_D ²⁰ = 119.5 (c 1.0, CHCl₃). ¹H NMR (500 MHz, CDCl₃): δ = 8.11 (d, J = 8.5 Hz, 2 H), 7.58 (d, J = 7.9 Hz, 2 H), 5.64 (d, J = 5.5 Hz, 1 H), 5.37 (t, J = 9.6 Hz, 1 H), 4.80 (dd, J = 11.9, 5.8 Hz, 1 H), 4.33 (dd, J = 11.9, 9.8 Hz, 1 H) , 4.29 (dd, J = 12.5, 5.2 Hz, 1 H), 4.25 (dd, J = 12.5, 2.4 Hz, 1 H), 3.94 (s, 3 H), 3.85 (ddd, J = 9.2, 4.9, 2.8 Hz, 1 H), 2.16 (s, 3 H), 2.06 (s, 3 H). ¹³C{¹H} NMR (126 MHz, CDCl₃): δ = 170.6, 169.0, 166.4, 152.6, 138.4, 130.7, 130.6 (2C), 126.5 (2C), 78.1, 77.7, 72.7, 72.3, 69.0, 62.1, 52.5, 20.9, 20.6. HRMS-ESI: m/z [M + Na]⁺ calcd for C₁₉H₂₀NaO₁₀: 431.0954; found: 431.0943.

Zusatzmaterial

Supporting Information